MedPath

Use of Self-management Group to Improve Quality of Life in Patients With Low Vision

Not Applicable
Withdrawn
Conditions
Age Related Macular Degeneration
Interventions
Behavioral: Self management program 'Living with Vision Loss'
Registration Number
NCT03046485
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Brief Summary

120 Patients with visual acuity \<6/12 will be randomized to receive either usual care or participate in a 6-week, 2 hour 'Living with Vision Loss' program led by trained leaders. We hypothesize that a structured self-management low-vision rehabilitation program provides a greater improvement in participation in daily activities, and improves quality of life in vision-impaired people compared to the provision of the usual low vision rehabilitation services. We also plan to document barriers that prevent patients with low vision (visual acuity \<6/12) from participating in self-management course.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Clients who have attended the MEEI Vision Rehabilitation for the first time within 12 months
  • Visual acuity of <6/12 in the better eye with habitual correction
  • Age 55+ years
  • Living independently (not in a nursing home)
  • English speaking
  • No cognitive impairment
  • Adequate hearing to respond to normal conversation
Exclusion Criteria
  • vestibular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Self management programSelf management program 'Living with Vision Loss'Self management program 'Living with Vision Loss' 6 week course that met for 2 hours each week led by a trained leader.
Primary Outcome Measures
NameTimeMethod
Impact of Vision Impairment Questionnaire (IVI)1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vision Rehabilitation Center

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath